[Hodgkin's disease: characteristics and prognosis of forms with initial bone marrow involvement (author's transl)]
- PMID: 7465354
[Hodgkin's disease: characteristics and prognosis of forms with initial bone marrow involvement (author's transl)]
Abstract
The distinctive features and prognosis of Hodgkin's disease with initial bone marrow involvement were studied in 53 patients. This form is characterized by clinical and biological signs of rapid evolution, diffuse lymphoid tissue involvement with enlarged liver and spleen, increased lymphocyte depletion and pancytopenia--the last named being rare in other forms. Sternberg cells were found in 80% of bone marrow biopsies, often associated which fibrosis, which always disappeared during remissions. Remission was obtained with multiple chemotherapy (chiefly MOPP) in 82% of the patients and was complet in 44%. Blood toxicity was severe in cases with myelofibrosis. Relapses occurred in 14 out of 39 patients and were either local and responsive to radiotherapy or diffuse and invariably lethal. They usually took place in those lymph nodes which were most affected initially. Additional radiotherapy and courses of MOPP reduce the risk of relapse. The long-term prognosis was similar to that of other visceral forms, with a survival rate leveling off at 83% after 6 years in patients in complete remission.
Similar articles
-
[Initial bone marrow involvement in Hodgkin's disease (author's transl)].Nouv Presse Med. 1981 Jan 24;10(3):147-50. Nouv Presse Med. 1981. PMID: 7220315 French.
-
Features and prognosis of chemotherapy-treated Hodgkin's disease with initial bone marrow involvement.Cancer Chemother Pharmacol. 1979;2(3):189-96. doi: 10.1007/BF00258294. Cancer Chemother Pharmacol. 1979. PMID: 455574
-
[Sites of relapse in Hodgkin's disease with bone marrow involvement treated by multiagent-chemotherapy (author's transl)].Bull Cancer. 1978;65(3):363-4. Bull Cancer. 1978. PMID: 719189 French. No abstract available.
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
-
Intensive therapy and autotransplantation in Hodgkin's disease.Stem Cells. 1994 Sep;12(5):477-93. doi: 10.1002/stem.5530120504. Stem Cells. 1994. PMID: 7804123 Review.
Cited by
-
Hodgkin's disease diagnosed post mortem: a population based study.Br J Cancer. 1993 Jan;67(1):185-9. doi: 10.1038/bjc.1993.32. Br J Cancer. 1993. PMID: 8427778 Free PMC article.
-
Lymphoproliferations in the bone marrow: identification and evolution, classification and staging.J Clin Pathol. 1984 Mar;37(3):233-54. doi: 10.1136/jcp.37.3.233. J Clin Pathol. 1984. PMID: 6699189 Free PMC article.
-
Bone marrow trephine biopsy in lymphoproliferative disease.J Clin Pathol. 1992 Sep;45(9):745-50. doi: 10.1136/jcp.45.9.745. J Clin Pathol. 1992. PMID: 1401199 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Medical